{"id":1930,"date":"2019-09-27T17:56:02","date_gmt":"2019-09-27T15:56:02","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1930"},"modified":"2024-03-06T11:49:52","modified_gmt":"2024-03-06T10:49:52","slug":"cancer-ginecologico","status":"publish","type":"page","link":"https:\/\/idibell.cat\/es\/investigacion\/area-de-cancer\/programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell\/cancer-ginecologico\/","title":{"rendered":"C\u00e1ncer Ginecol\u00f3gico"},"content":{"rendered":"\n
El grupo de C\u00e1ncer ginecol\u00f3gico es un equipo multidisciplinar formado por ginec\u00f3logos, onc\u00f3logos, pat\u00f3logos e investigadores b\u00e1sicos. El grupo cuenta con tres l\u00edderes, Xavier Matias-Guiu, tambi\u00e9n l\u00edder del grupo CIBER (CB16 \/ 12\/00231, conjuntamente con IRBLLEIDA), Jordi Ponce, Mireia Martin-Satu\u00e9, David Llobet y Ruth Rodriguez-Barrueco. El grupo acaba de iniciar el trabajo colaborativo en diferentes \u00e1reas del c\u00e1ncer ginecol\u00f3gico.<\/p>\n
<\/p>\n
Herzog,C;Mar\u00edn,F;Jones,A;Evans,I;Reisel,D;Redl,E;Schreiberhuber,L et al, A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case\/Control Sets<\/strong>., J. Clin. Oncol., 2022;40(33):3828-doi:10.1200\/JCO.22.00266<\/p>\n Jim\u00e9nez,C;Antonelli,R;Nadal Ribelles,M;Devis Jauregui,L; Latorre,P; Sol\u00e9,C; Masanas,M et al, Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program<\/strong>., Mol. Cancer, 2022;21(1):175-175, doi:10.1186\/s12943-022-01643-4<\/p>\n Muelas Fernandez,M;Lerida Urteaga,A;Paules Villar,MJ;Vidal Bel,A;Ruiz Pombo,M, Strongyloides hyperinfection in a patient from Venezuela with lower gastrointestinal bleeding<\/strong>., J. Travel Med., 2022;29(1):doi:10.1093\/jtm\/taab084<\/p>\n Rodr\u00edguez Barrueco,R;Latorre,J;Devis J\u00e1uregui,L; Lluch,A; Bonifaci,N;Llobet, FJ; livan,M et al, A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG<\/strong>., Adv. Sci., 2022;9(4):doi:10.1002\/advs.202104759<\/p>\n Pan\u00e9 Foix,M;Fernandez Calvo,D;Condom Mund\u00f3,I;Suarez Novo,JF;Merino Serra,E; Garcia Benett,JR; Gom\u00e0 G\u00e0llego,M et al, Clinical relevance of amyloid in prostate samples: a report on 40 patients<\/strong>., Histopathology, 2022;81(3):363-370, doi:10.1111\/his.14717<\/p>\n\t\t\t\t\tProyectos seleccionados<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t 17ACL120. A PHASE IA\/B OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARACOKINETICS OF MTIG7192A AS A SINGLE AGENT AND INCOMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC TUMORS<\/strong>. Genentech, Inc. Budget: 619866. 2017-2026. PI: Gil Martin, Marta.<\/p>\n 19PSJ014. TARGETING THE AUTORESISTOME AS A NEW THERAPEUTIC STRATEGY IN ENDOMETRIAL CANCER<\/strong>. Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC). Budget: 299849,22. 2019-2023. PI: Llobet Nav\u00e0s, David.<\/p>\n 17ACL048. ESTUDIO DE FASE IB, ABIERTO Y MULTIC\u00c9NTRICO, PARA CARACTERIZAR LA SEGURIDAD, TOLERABILIDAD Y FARMACODIN\u00c1MICA (PD) DE PDR001 EN COMBINACI\u00d3N CON CJM112, EGF816, ILARIS (CANAKINUMAB) O MEKINIST (TRAMETINIB)<\/strong>. Budget: 283580. 2017- . PI: Gil Martin, Marta.<\/p>\n 18ACL156. ESTUDIO DE FASE I, ABIERTO, MULTIC\u00c9NTRICO, DE B\u00daSQUEDA DE DOSIS DE TNO155 ORAL EN PACIENTES ADULTOS CON TUMORES S\u00d3LIDOS AVANZADOS<\/strong>. Novartis Farmac\u00e9utica, S.A. Budget: 233522. 2018- . PI: Gil Martin, Marta.<\/p>\n 18PSJ022. Targeting the most aggressive type of endometrial carcinoma. Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)<\/strong>. Budget: 203000. 2018-2024. PI: Mat\u00edas-Guiu Guia, Xavier.<\/p>\n\t\t\t\t\tM\u00e1s informaci\u00f3n<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t El grupo cuenta con proyectos activos financiados por ISCIII, MINECO y organismos privados (Merck-Serono, MSD), y un buen historial de publicaciones en revistas de revisi\u00f3n por pares.<\/p>\n <\/p>\nCULTIVOS 3D PERSONALIZADOS PARA SELECCI\u00d3N DE TRATAMIENTO PARA PACIENTES DE C\u00c1NCER EN MEDICINA DE PRECISI\u00d3N (PROYECTO 3D-ID)<\/strong> <\/p>\n\t\t\t\t\n C\u00e1ncer Ginecol\u00f3gico Resumen El grupo de C\u00e1ncer ginecol\u00f3gico es un equipo multidisciplinar formado por ginec\u00f3logos, onc\u00f3logos, pat\u00f3logos e investigadores b\u00e1sicos. El grupo cuenta con tres l\u00edderes, Xavier Matias-Guiu, tambi\u00e9n l\u00edder del grupo CIBER (CB16 \/ 12\/00231, conjuntamente con IRBLLEIDA), Jordi Ponce, Mireia Martin-Satu\u00e9, David Llobet y Ruth Rodriguez-Barrueco. El grupo acaba de iniciar el trabajo […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-11 14:21:21","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/1930"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=1930"}],"version-history":[{"count":8,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/1930\/revisions"}],"predecessor-version":[{"id":23963,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/1930\/revisions\/23963"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=1930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nPI: Matias-Guiu, Xavier
\nConvocatoria Retos Colaboraci\u00f3n, expediente: RTC-2017- 6573-1
\nCoordinador: STEMTEK THERAPEUTICS, S.L.
\nMinisterio de Ciencia, Innovaci\u00f3n y Universidades, perteneciente a la Agencia Estatal de Investigaci\u00f3n (AEI).
\nCofinanciado por el Fondo Europeo de Desarrollo Regional. FEDER, una manera de hacer Europa. Promover el desarrollo tecnol\u00f3gico, la innovaci\u00f3n y una investigaci\u00f3n de calidad.\n
\n\n\n\t\tMatias-Guiu Guia, Xavier\n\t<\/h4>\n
\n\t\t\n\t\txmatias@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadores principales\n\t<\/h2>\n\t\t\t\t\n
\n\t\tMatias-Guiu Guia, Xavier\n\t<\/h4>\n
\n\t\t\n\t\txmatias@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tMart\u00edn Satu\u00e9, Mireia\n\t<\/h4>\n
\n\t\t\n\t\tmmartin@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tPonce Sebastia, Jordi\n\t<\/h4>\n
\n\t\t\n\t\tjponce@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tLlobet Navas, David\n\t<\/h4>\n
\n\t\t\n\t\tdllobet@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tGil Martin, Marta\n\t<\/h4>\n
\n\t\t\n\t\tmgil@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tRodriguez Barrueco, Ruth\n\t<\/h4>\n
\n\t\t\n\t\trrodriguezb@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tPardo Burdalo, Beatriz\n\t<\/h4>\n
\n\t\t\n\t\tbpardo@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tENLACES RELACIONADOS\n\t<\/h4>\n
\n\t\t\n\t\t@xmatiasguiu\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@DLN_Lab\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@RRdguezBarrueco\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquipo\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tJefes\/as de grupo\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as principales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as cl\u00ednicos\/as\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as postdoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadores\/as predoctorales\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSoporte cient\u00edfico\t\t\t\t<\/a>\n\t\t\t\t\t\tJefes\/as de grupo\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n
\n\t\tNoticias relacionadas\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn estudio del IDIBELL y el IDIBGI eval\u00faa la eficacia de un anti-tumoral en la lucha contra la obesidad<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t01\/08\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tSe demuestran los buenos resultados de la rob\u00f3tica en la cirug\u00eda de c\u00e1ncer de cuello uterino<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t07\/03\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIdentifican una mol\u00e9cula que podr\u00eda participar en la formaci\u00f3n de met\u00e1stasis \u00f3seas en el c\u00e1ncer de pr\u00f3stata<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t25\/01\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescubren una nueva v\u00eda de regulaci\u00f3n gen\u00e9tica asociada a la obesidad<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/12\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tmiR-424~503, un grupo de microRNAs que controlan el desarrollo de un tipo de c\u00e1ncer de mama<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t14\/10\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl Dr. Xavier Matias-Guiu, nuevo presidente de la Sociedad Internacional de Pat\u00f3logos Ginecol\u00f3gicos<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t19\/03\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL celebra el Kickoff Meeting AES 2019 sobre Proyectos de Investigaci\u00f3n en Salud financiados por el ISCIII<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/03\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDavid Llobet y Eva Gonz\u00e1lez Su\u00e1rez reciben ayudas de la AECC en el D\u00eda Mundial de la Investigaci\u00f3n del C\u00e1ncer<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t24\/09\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLos an\u00e1lisis moleculares podr\u00edan mejorar la detecci\u00f3n precoz y la prevenci\u00f3n del c\u00e1ncer de endometrio<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t17\/06\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tRuth Rodr\u00edguez Barrueco, Premio de Investigaci\u00f3n L’Or\u00e9al-UNESCO \u00abFor women in science\u00bb<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t28\/11\/2018\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"